EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Benefit of Autologous Platelet-Rich Plasma Infusion in Ovarian Function Rejuvenation: Evidence from a Before-After Prospective Pilot Study

Athanasios Garavelas iD, Panagiotis Mallis iD, Efstathios Michalopoulos iD, Eros Nikitos

Medicines · 27.02.2023 · 10 (3) · 19

DOI: 10.3390/medicines10030019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicines, online erschienen am 27.02.2023. Verfasst von Athanasios Garavelas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Life, IASO Maternity Hospital, 37-39, Kifissias Avenue, 151 23 Athens, Greece. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The intraovarian administration of autologous platelet-rich plasma (PRP) acts beneficially for the stimulation of follicle production in women presenting different forms of ovarian dysfunction. This pilot study aimed to evaluate and provide significant data regarding the efficacy of PRP to rejuvenate the ovaries.

Methods

A total of 253 women aged 22–56 years, were divided into five groups, based on their status. All participants signed for informed consent for the current study. Blood sampling, preparation of PRP and intraovarian infusion of the latter were performed on all participants. The evaluation of PRP efficacy, a two-month follow-up detecting the levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2) and anti-mullerian hormone (AMH), was performed for all participants. For women with advanced ages (>48 years), the restoration and regularity of the menstrual cycle were additionally evaluated.

Results

After the two-month follow-up, the majority of the participants presented improvement in their hormonal profiles. Additionally, 17% of the women in this pilot study successfully conceived. The restoration of the menstrual cycle was detected in 15% of the women with advanced ages.

Conclusions

Intraovarian infusion of autologous PRP exhibited remarkable evidence and promising results to restore ovarian insufficiency.

Schlagwörter

Stichwörter der Autor:innen

AMHFSHfolliclesgrowth factorshormone therapymenopauseovarian insufficiencyplatelet-rich plasma

Autor:innen und Institutionen

  • Institute of Life, IASO Maternity Hospital, 37-39, Kifissias Avenue, 151 23 Athens, Greece.
  • Hellenic Cord Blood Bank, Biomedical Research Foundation Academy of Athens, 4 Soranou Efessiou Street, 115 27 Athens, Greece.

ORCID-Profile: Athanasios Garavelas, Panagiotis Mallis, Efstathios Michalopoulos

Zitieren

APA

Garavelas, A., Mallis, P., Michalopoulos, E., & Nikitos, E. (2023). Clinical Benefit of Autologous Platelet-Rich Plasma Infusion in Ovarian Function Rejuvenation: Evidence from a Before-After Prospective Pilot Study. Medicines, 10(3), 19. https://doi.org/10.3390/medicines10030019

Vancouver

Garavelas A, Mallis P, Michalopoulos E, Nikitos E. Clinical Benefit of Autologous Platelet-Rich Plasma Infusion in Ovarian Function Rejuvenation: Evidence from a Before-After Prospective Pilot Study. Medicines. 2023;10(3):19. doi:10.3390/medicines10030019

BibTeX
@article{Garavelas2023,
  author = {Garavelas, Athanasios and Mallis, Panagiotis and Michalopoulos, Efstathios and Nikitos, Eros},
  title = {Clinical Benefit of Autologous Platelet-Rich Plasma Infusion in Ovarian Function Rejuvenation: Evidence from a Before-After Prospective Pilot Study},
  journal = {Medicines},
  year = {2023},
  volume = {10},
  number = {3},
  pages = {19},
  doi = {10.3390/medicines10030019}
}
Kostenlos starten →